Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra

Table 2

Demographics.

	HAART Experienced; (𝑛=331); 𝑛 (%)	HAART Naive; (𝑛=72); 𝑛 (%)	𝑃 value
Sex:			0.25
Female	159 (48.0)	40 (55.5)
Male	172 (52.0)	32 (44.4)
Average age (months)	108.1±41.4	97.3±40.7	0.05*
Average age at diagnosis (months)	55.7±37.5	63.6±39.1	0.09
Congenital transmission	320 (99.1)	70 (98.6)	0.55
Exposure to prenatal ART:	6 (1.8)	6 (1.5)	0.60
Current WHO stage:			<0.0001*
I	27 (8.2)	24 (34.3)
II	56 (17.0)	22 (31.4)
III	154 (46.7)	13 (18.6)
IV	93 (28.2)	11 (15.7)

∗Statistical significance.